AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Foulon, CF Welsh, PC Bigner, DD Zalutsky, MR
Citation: Cf. Foulon et al., Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-Iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR, NUCL MED BI, 28(7), 2001, pp. 769-777

Authors: Foulon, CF Reist, CJ Bigner, DD Zalutsky, MR
Citation: Cf. Foulon et al., Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody, CANCER RES, 60(16), 2000, pp. 4453-4460

Authors: Kuan, CT Reist, CJ Foulon, CF Lorimer, IAJ Archer, G Pegram, CN Pastan, I Zalutsky, MR Bigner, DD
Citation: Ct. Kuan et al., I-125-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts, CLIN CANC R, 5(6), 1999, pp. 1539-1549

Authors: Foulon, CF Bigner, DD Zalutsky, MR
Citation: Cf. Foulon et al., Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting applications, BIOCONJ CHE, 10(5), 1999, pp. 867-876

Authors: Zalutsky, MR Xu, FJ Yu, Y Foulon, CF Zhao, XG Slade, SK Affleck, DJ Bast, RC
Citation: Mr. Zalutsky et al., Radioiodinated antibody targeting of the HER-2/neu oncoprotein: Effects oflabeling method on cellular processing and tissue distribution, NUCL MED BI, 26(7), 1999, pp. 781-790

Authors: Reist, CJ Foulon, CF Alston, K Bigner, DD Zalutsky, MR
Citation: Cj. Reist et al., Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[At-211]astato-3-pyridinecarboxylate, NUCL MED BI, 26(4), 1999, pp. 405-411
Risultati: 1-6 |